TELA Bio Revenue 2024

TELA Bio Revenue

76.91 M USD

TELA Bio Dividend yield

Ticker

TELA

ISIN

US8723811084

WKN

A2PUP9

In 2024, TELA Bio's sales reached 76.91 M USD, a 31.58% difference from the 58.45 M USD sales recorded in the previous year.

The TELA Bio Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e207.9419,29
2027e162.7524,65
2026e125.6431,93
2025e97.5741,11
2024e76.9152,15
202358.4568,62
202241.4265,28
202129.4663,85
202018.2161,67
201915.4560,00
20188.2735,55
20174.2559,53

TELA Bio Aktienanalyse

What does TELA Bio do?

TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding TELA Bio's Sales Figures

The sales figures of TELA Bio originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing TELA Bio’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize TELA Bio's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in TELA Bio’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about TELA Bio Stock

How much revenue did TELA Bio generate this year?

TELA Bio has achieved a revenue of 76.91 M USD this year.

How much was the turnover of the company TELA Bio compared to the previous year?

The revenue of TELA Bio has increased by 31.58% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of TELA Bio?

The revenue of TELA Bio is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of TELA Bio measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of TELA Bio so important for investors?

The revenue of TELA Bio is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does TELA Bio pay?

Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.

What is the dividend yield of TELA Bio?

The current dividend yield of TELA Bio is .

When does TELA Bio pay dividends?

TELA Bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TELA Bio?

TELA Bio paid dividends every year for the past 0 years.

What is the dividend of TELA Bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TELA Bio located?

TELA Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TELA Bio from 5/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/25/2024.

When did TELA Bio pay the last dividend?

The last dividend was paid out on 5/25/2024.

What was the dividend of TELA Bio in the year 2023?

In the year 2023, TELA Bio distributed 0 USD as dividends.

In which currency does TELA Bio pay out the dividend?

The dividends of TELA Bio are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TELA Bio

Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.